NHGRI source snapshot
2019 State Bills Louisiana 2019 HB 345
Louisiana
Retrieved from NHGRI
NHGRI summary
Requires health plans to cover the cost of the genetic testing of the BRCA1 and BRCA2 genes to detect an increased risk for breast and ovarian cancer when recommended by a healthcare provider in accordance with the United States Preventive Services Task Force recommendations. Signed by the Governor June 5, 2019. Effective January 1, 2020.
Source links
- Open the primary link recorded by NHGRI
- View the NHGRI Genome Statute and Legislation Database
- Browse other Louisiana source records
Legacy link: NHGRI recorded this destination using unencrypted HTTP. The link may be stale or unavailable.
Provenance
Courtesy: National Human Genome Research Institute. This source layer preserves the state, primary link, topic, bill status, and summary retrieved from NHGRI.